Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reissue Patent
2006-02-02
2010-06-22
Anderson, James D (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S183000, C514S922000
Reissue Patent
active
RE041393
ABSTRACT:
Methods of treating tumors in a mammal, especially a human that has demonstrated resistance to other chemotherapeutic agents, is disclosed. Specifically, methods of the present invention are effective in tumors that have initially been unresponsive to taxane therapy, or have developed resistance during the course of treatment. The methods of the present invention comprise administering epothilone derivatives selected from those represented by the formula:The subject epothilone derivatives are advantageous in addition to their enhanced potency and effectiveness against tumors that have demonstrated resistance to therapy with taxane oncology agents in that they are efficacious upon oral administration.
REFERENCES:
patent: 5969145 (1999-10-01), Schinzer et al.
patent: 6194181 (2001-02-01), Hofmann et al.
patent: 6204388 (2001-03-01), Danishefsky et al.
patent: 6211412 (2001-04-01), Georg et al.
patent: 6242469 (2001-06-01), Danishefsky et al.
patent: 6262094 (2001-07-01), Hoefle et al.
patent: 6302838 (2001-10-01), O'Reilly et al.
patent: 6316630 (2001-11-01), Danishefsky et al.
patent: 6365749 (2002-04-01), Kim et al.
patent: 6369234 (2002-04-01), Danishefsky et al.
patent: 6518421 (2003-02-01), Li et al.
patent: 6576651 (2003-06-01), Bandyopadhyay et al.
patent: 6593115 (2003-07-01), Vite et al.
patent: 6605599 (2003-08-01), Vite et al.
patent: 6670384 (2003-12-01), Bandyopadhyay et al.
patent: 6689802 (2004-02-01), DiMarco et al.
patent: 6867305 (2005-03-01), Danishefsky et al.
patent: 6982276 (2006-01-01), DiMarco et al.
patent: 2002/0010213 (2002-01-01), Sawyer et al.
patent: 2002/0143038 (2002-10-01), Bandyopadhyay et al.
patent: 2002/0160354 (2002-10-01), Cabot
patent: 2002/0177615 (2002-11-01), Bandyopadhyay et al.
patent: 2003/0073677 (2003-04-01), Lee
patent: 2004/0023345 (2004-02-01), Vite et al.
patent: 2004/0024032 (2004-02-01), Voi et al.
patent: 2004/0076177 (2004-04-01), Koch et al.
patent: 2004/0132146 (2004-07-01), Benigini et al.
patent: 2004/0214871 (2004-10-01), Lee
patent: 2005/0159461 (2005-07-01), Lee
patent: 4138042.8 (1993-05-01), None
patent: 19542986.9 (1997-05-01), None
patent: 19639456.2 (1997-05-01), None
patent: 19636343.8 (1998-03-01), None
patent: 19645361.5 (1998-04-01), None
patent: 19645362.3 (1998-04-01), None
patent: 19647580.5 (1998-05-01), None
patent: 19701758 (1998-07-01), None
patent: 19707505.3 (1998-09-01), None
patent: 19713970 (1998-10-01), None
patent: 19720312 (1998-11-01), None
patent: 19821954 (1998-11-01), None
patent: 19726627 (1998-12-01), None
patent: 879 605 (1998-11-01), None
patent: 93/10121 (1993-05-01), None
patent: 97/19086 (1997-05-01), None
patent: 98/08849 (1998-03-01), None
patent: 98/22461 (1998-05-01), None
patent: 98/24427 (1998-06-01), None
patent: 98/25929 (1998-06-01), None
patent: 98/38192 (1998-09-01), None
patent: 98/47891 (1998-10-01), None
patent: 99/01124 (1999-01-01), None
patent: 99/02514 (1999-01-01), None
patent: 99/03848 (1999-01-01), None
patent: 99/07692 (1999-02-01), None
patent: 99/27890 (1999-06-01), None
patent: 99/39694 (1999-08-01), None
patent: 99/42602 (1999-08-01), None
patent: 99/43320 (1999-09-01), None
patent: 99/43653 (1999-09-01), None
patent: 99/54319 (1999-10-01), None
patent: 99/67252 (1999-12-01), None
patent: 00/00485 (2000-01-01), None
patent: 00/31247 (2000-06-01), None
patent: 00/37473 (2000-06-01), None
patent: 00/49021 (2000-08-01), None
patent: WO 00/50423 (2000-08-01), None
patent: 00/68589 (2000-11-01), None
U.S. Appl. No. 08/856,533 filed May 14, 1997, K. Nicolaou et al.
U.S. Appl. No. 08/923,869 filed Sep. 4, 1997, K. Nicolaou et al.
U.S. Appl. No. 60/032,864 filed Dec. 13, 1996, K. Nicolaou et al.
Balog, A., et al., “Total Synthesis of (-)-Epothilone A”,Angew. Chem. Int. Ed. Eng., vol. 35, No. 23/24, 2801-2803 (1996).
Bertini, F., et al., “Alkenes from Epoxides by Reductive Elimination with Magnesium Bromide-Magnesium Amalgam”,Chem. Commun., 144 (1970).
Bollag, D.M., et al., “Epothilones, A New Class of Microtubule-stabilizing Agents with a Taxol-like Mechanism of Action”,Cancer Res.55, No. 11, 2325-2333 (1995).
Fujisawa, T., et al., “Deoxygenation of Epoxides to Olefins with FeCl3-n-BuLi System”,Chem. Lett., 883-886 (1974).
Fujiwara, Y., et al., “Reductive Coupling of Carbonyl Compounds to Olefins by Tungsten Hexachloride-Lithium Aluminum Hydride and Some Tungsten and Molybdenum Carbonyls”,J. Org. Chem., vol. 43, No. 12, 2477-2479 (1978).
Gladysz, J.A., et al., “Deoxygenation of Epoxides by Metal Atom Cocondensation”,J. Org. Chem., vol. 41, No. 22, 3647-3648 (1976).
Hoffe, G., et al., “Epothilone A and B—Novel 16—Membered Macrolides with Cytotoxic Activity: Isolation, Crystal Structure, and Conformation in Solution”,Angew. Chem. Int. Ed. Engl., vol. 35, No. 13/14, 1567-1569 (1996).
Hoffe, G., et al., “N-Oxidation of Epothilone A-C and O-Acyl Rearrangement to C-19 and C-21—Substituted Epothilones”,Angew. Chem. Int. Ed., vol. 38, No. 13/14, 1971-1974 (1999).
Inokuchi, T., et al., “Opening of Epoxides to Olefins or Halohydrins with Vanadium (ll)-Tetrahydrofuran or Vanadium (III)—Tetrahydrofuran Complexes”,Synlett, No. 6, 510-512 (1992).
Kowalski, R. J., et al., “Activities of the Microtubule-stablizing Agents Epothilones A and B with Purified Tubulin and in Cells Resistant to Paclitaxel (Taxol®)”J. Biol. Chem., vol. 272, No. 4, 2534-2541 (1997).
Kupchan, S. M., et al., “Reductive Elimination of Epoxides to Olefins with Zinc-Coppper Couple”,J. Org. Chem., vol. 36, No. 9, 1187-1190 (1971).
Martin, M. G., et al., “Epoxides as Alkene Protecting Groups. A Mild and Efficient Deoxygenation”,Tetrahedron Letters, vol. 25, No. 3, 251-254 (1984).
McMurry, J. E., et al., “Reduction of Epoxides to Olefins with Low Valent Titanium”,J. Org. Chem., vol. 40, No. 17, 2555-2556 (1975).
McMurry, J.E., et al., “Some Deoxygenation Reactions with Low-Valent Titanium (TiCL/LiAIH4)”,J. Org. Chem., vol. 43, No. 17, 3249-3254.
Meng, D., et al., “Remote Effects in Macrolide Formation Through Ring-Forming Olefin Methathesis: An Application to the Synthesis of Fully Active Epothilone Congeners”,J. Am. Chem. Soc., vol. 119, No. 11, 2733-2734 (1997).
Nicolaou, K. C., et al., “An Approach to Epothilones Based on Olefin Metathesis”, Angew.Chem. Int. Ed. Engl., vol. 35, No. 20, 2399-2401(1996).
Nicolaou, K. C., et al., “Total Syntheses of Epothilone A: The Macrolactonization Approach”,Angew. Chem. Int. Engl., vol. 36, No. 5, 525-527 (1997).
Nicolaou, K. C., et al., “Designed Epothilones: Combinatorial Synthesis, Tubulin Assembly Properties, and Cytotoxic Action against Taxol-Resistant Tumor Cells”,Angew. Chem. Int. Ed. Engl., vol. 36, No. 19, 2097-2103 (1997).
Nicolaou, K.C., et al., “The Olefin Metathesis Approach to Epothilone A and Its Analogues”,J. Am. Chem. Soc., vol. 119, No. 34, 7960-7973 (1997).
Nicolaou, K.C., et al., “Total Synthesis of Epothilones A and B via a Macrolactonization-Based Strategy”,J. Am. Chem. Soc., vol. 119, No. 34, 7974-7991 (1997).
Nicolaou, K. C., et al., “Synthesis of Epothilones A and B in Solid and Solution Phase”,Nature, vol. 387, 268-272 (1997).
Nicolaou, K. C., et al., “Synthesis of Epothilones A and B in Solid and Solution Phase” (Correction to Nature 387, 268-272 (1997)),Nature, 390, 100 (1997).
Raucher, S., et al., “Total Synthesis of (+)-Dihydrocostunolide via Tandem Cope-Claisen Rearrangement”,J. Org. Chem., vol. 51, No. 26, 5503-5505 (1986).
Sato, M, et al., “Reduction of Organic Compounds with Low-Valent Niobium (NbCl5/NaAlH4)”,Chem. Letters., 157-160 (1982).
Schinzer, D., et al., “Total Synthesis of (-)-Epothilone A”,Angew. Chem. Int. Ed. Engl., vol. 36, No. 5, 523-524 (1997).
Schobert, R., et al., “Reduction and Isomerization of Oxiranes and α-Diazoketones by Various Ea
Anderson James D
Bristol--Myers Squibb Company
Winslow Anastasia P.
LandOfFree
Treatment of refractory tumors using epothilone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of refractory tumors using epothilone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of refractory tumors using epothilone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4247232